Urba WJ - Search Results

1

Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer.

Gause BL, Sznol M, Kopp WC, Janik JE, Smith JW 2nd, Steis RG, Urba WJ, Sharfman W, Fenton RG, Creekmore SP, Holmlund J, Conlon KC, VanderMolen LA, Longo DL. Gause BL, et al. Among authors: urba wj. J Clin Oncol. 1996 Aug;14(8):2234-41. doi: 10.1200/JCO.1996.14.8.2234. J Clin Oncol. 1996. PMID: 8708712 Clinical Trial.

2

Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.

Urba WJ, Wilson WH, Duffey PL, Wittes R, Chabner BA, Longo DL. Urba WJ, et al. Semin Oncol. 1992 Dec;19(6 Suppl 13):26-32. Semin Oncol. 1992. PMID: 1283467 Review.

3

Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study.

Sznol M, Steis RG, Smith JW 2nd, Janik JE, Sharfman WH, Urba WJ, Fenton RG, Creekmore SP, Beveridge J, Longo DL. Sznol M, et al. Among authors: urba wj. Online J Curr Clin Trials. 1992 Jul 1;Doc No 9:[3841 words; 32 paragraphs]. Online J Curr Clin Trials. 1992. PMID: 1343617 Clinical Trial.

4

Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells.

Loeffler CM, Smyth MJ, Longo DL, Kopp WC, Harvey LK, Tribble HR, Tase JE, Urba WJ, Leonard AS, Young HA, et al. Loeffler CM, et al. Among authors: urba wj. J Immunol. 1992 Aug 1;149(3):949-56. J Immunol. 1992. PMID: 1353099

5

Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.

Conlon KC, Ochoa AC, Kopp WC, Ortaldo JR, Urba WJ, Longo DL, Young HA. Conlon KC, et al. Among authors: urba wj. J Immunol. 1992 Nov 15;149(10):3278-89. J Immunol. 1992. PMID: 1358968

6

Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes.

Ochoa JB, Curti B, Peitzman AB, Simmons RL, Billiar TR, Hoffman R, Rault R, Longo DL, Urba WJ, Ochoa AC. Ochoa JB, et al. Among authors: urba wj. J Natl Cancer Inst. 1992 Jun 3;84(11):864-7. doi: 10.1093/jnci/84.11.864. J Natl Cancer Inst. 1992. PMID: 1375656 Clinical Trial.

7

Adoptive cellular therapy.

Sznol M, Urba WJ. Sznol M, et al. Among authors: urba wj. Cancer Chemother Biol Response Modif. 1992;13:191-204. Cancer Chemother Biol Response Modif. 1992. PMID: 1389910 Review. No abstract available.

8

Anti-CD3 monoclonal antibody treatment of patients with CD3-negative tumors: a phase IA/B study.

Urba WJ, Ewel C, Kopp W, Smith JW 2nd, Steis RG, Ashwell JD, Creekmore SP, Rossio J, Sznol M, Sharfman W, et al. Urba WJ, et al. Cancer Res. 1992 May 1;52(9):2394-401. Cancer Res. 1992. PMID: 1533172 Clinical Trial.

9

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.

Ewel CH, Urba WJ, Kopp WC, Smith JW 2nd, Steis RG, Rossio JL, Longo DL, Jones MJ, Alvord WG, Pinsky CM, et al. Ewel CH, et al. Among authors: urba wj. Cancer Res. 1992 Jun 1;52(11):3005-10. Cancer Res. 1992. PMID: 1591717 Clinical Trial.

10

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.

Smith JW 2nd, Urba WJ, Curti BD, Elwood LJ, Steis RG, Janik JE, Sharfman WH, Miller LL, Fenton RG, Conlon KC, et al. Smith JW 2nd, et al. Among authors: urba wj. J Clin Oncol. 1992 Jul;10(7):1141-52. doi: 10.1200/JCO.1992.10.7.1141. J Clin Oncol. 1992. PMID: 1607919 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters